Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor

Disease Name: 
Solid tumors with KRAS G12V mutation
Study Status: 
Recruiting
Date: 
March 19, 2025
Detail Link ( on-site link ): 
/phase-i-study-autologous-cd8-and-cd4-engineered-t-cell-receptor-t-cells-subject…